Literature DB >> 9885904

CD45RA(bright)/CD11a(bright) CD8+ T cells: effector T cells.

C Höflich1, W D Döcke, A Busch, F Kern, H D Volk.   

Abstract

An important aspect of peripheral T cell development is the differentiation from naive into memory cells. To distinguish naive from memory cells, CD45RA and CD11a are commonly used: CD45RA+ or CD11a(dim) T cells are regarded as naive, while CD45RA- or CD11a(bright) T cells are thought to be of memory type. There is, however, a CD8+ T cell subset which is CD45RA+ and at the same time CD11a(bright). It increases with age and in patients with systemic viral infections, though its functional role in the immune response is unknown. In the present study, we give evidence that this subset is related to memory-like T cells as it produces IFN-gamma and tumor necrosis factor-alpha, contains high levels of perforin, and expresses CD95 in the same way as memory-type CD45RA-/CD11a(bright) CD8+ T cells. Since it contains a high percentage of CD28- and CD57+ cells, is increased in size and granularity, and is transiently expressed following in vitro stimulation of naive CD8+ T cells, we speculate that this subset mainly represents recently activated effector T cells that are able to interact with CD80 and CD86 (B7-1 and B7-2 respectively) negative tissue cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9885904     DOI: 10.1093/intimm/10.12.1837

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles.

Authors:  K Lima; T G Abrahamsen; I Foelling; S Natvig; L P Ryder; R W Olaussen
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

2.  Analysis of the susceptibility of CD57 T cells to CD3-mediated apoptosis.

Authors:  N Shinomiya; Y Koike; H Koyama; E Takayama; Y Habu; M Fukasawa; S Tanuma; S Seki
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

3.  Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody.

Authors:  Hao Wang; Zhixiang Zhang; Weijun Tian; Tong Liu; Hongqiu Han; Bertha Garcia; Xian C Li; Caigan Du
Journal:  Cardiovasc Drugs Ther       Date:  2014-04       Impact factor: 3.727

4.  Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.

Authors:  Srikanth Manam; Joshua D Thomas; Weidang Li; Allison Maladore; Justin H Schripsema; Kyle H Ramsey; Ashlesh K Murthy
Journal:  J Infect Dis       Date:  2014-12-30       Impact factor: 5.226

5.  Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy.

Authors:  L Fong; Y Hou; A Rivas; C Benike; A Yuen; G A Fisher; M M Davis; E G Engleman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

6.  Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process.

Authors:  Valentina Libri; Rita I Azevedo; Sarah E Jackson; Diletta Di Mitri; Raskit Lachmann; Stephan Fuhrmann; Milica Vukmanovic-Stejic; Kwee Yong; Luca Battistini; Florian Kern; Maria V D Soares; Arne N Akbar
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

7.  Growth hormone enhances thymic function in HIV-1-infected adults.

Authors:  Laura A Napolitano; Diane Schmidt; Michael B Gotway; Niloufar Ameli; Erin L Filbert; Myra M Ng; Julie L Clor; Lorrie Epling; Elizabeth Sinclair; Paul D Baum; Kai Li; Marisela Lua Killian; Peter Bacchetti; Joseph M McCune
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Maintenance of naïve CD8 T cells in nonagenarians by leptin, IGFBP3 and T3.

Authors:  Jian Chen; Jun Li; Fei Chu Lim; Qi Wu; Daniel C Douek; Donald K Scott; Eric Ravussin; Hui-Chen Hsu; S Michal Jazwinski; John D Mountz
Journal:  Mech Ageing Dev       Date:  2009-11-24       Impact factor: 5.432

9.  CD8beta/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes.

Authors:  S Werwitzke; A Tiede; B E Drescher; R E Schmidt; T Witte
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.

Authors:  Li Yin; Carina A Rodriguez; Wei Hou; Olivia Potter; Margaret J Caplan; Maureen M Goodenow; John W Sleasman
Journal:  J Allergy Clin Immunol       Date:  2008-06-09       Impact factor: 10.793

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.